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Inflammation and dietary protein intake exert competing ef- Laboratory abnormalities associated with the syn-
fects on serum albumin and creatinine in hemodialysis patients. drome known as “protein energy malnutrition” are po-
Background. Cross-sectional studies have shown an inverse tent predictors of mortality and morbidity in hemodialy-correlation between serum C-reactive protein (CRP) and se-
sis patients [1]. These include the serum concentrationrum albumin concentration in hemodialysis patients. The net
of visceral proteins, such as albumin and prealbumineffects of inflammation and dietary protein intake on nutri-
tional markers over time are unknown. (transthyretin), and markers of somatic protein mass,
Methods. To explore the effects of CRP and normalized including changes in body weight, Quetelet’s index, mid-
protein catabolic rate (nPCR) on serum albumin and creati-
arm muscle circumference, and serum creatinine [2–6].nine, we analyzed six consecutive months of laboratory data
While the levels of serum albumin have been thoughtfrom 364 hemodialysis patients, using a multivariable Mixed
model with conservative biases. for decades to correlate directly and strongly with dietary
Results. The overall trend over time in serum albumin was protein intake, only recently have investigators and clini-
slightly positive (0.039 g/dL/month) and in serum creatinine cians appreciated the influence of inflammation on theslightly negative (0.052 mg/dL/month). With increasing CRP,
serum albumin concentration.serum albumin declined significantly (0.124 g/dL/month per
The presence and intensity of the inflammatory re-unit increase in log CRP, adjusted for age, gender, race, diabe-
tes, and nPCR, P  0.0001). Serum albumin increased with sponse have been classified by levels of proteins of the
increasing nPCR (0.021 g/dL/month per 0.1 g/kg/day, P  acute phase response, such as C-reactive protein (CRP)
0.0001). The effect of CRP on albumin was attenuated in Afri-
or serum amyloid A (SAA) or the cytokines that regulatecan Americans and at a higher nPCR. Corresponding values for
them [for example, tumor necrosis factor- (TNF-),creatinine mirrored those for albumin. With increasing CRP,
creatinine declined significantly [0.142 mg/dL/month per unit interleukin-1 (IL-1), and IL-6] [7, 8]. Large cross-sec-
increase in log CRP, adjusted for age, gender, race, diabetes tional studies have identified these markers of inflamma-
(time since initiation of dialysis; vintage), Kt/V, and nPCR, tion as powerful predictors of coronary and cerebrovas-P  0.002]. Serum creatinine increased with increasing nPCR
cular disease in the general population [9–11], and we(0.183 mg/dL/month per g/kg/day, P  0.0001).
[12] and others [13, 14] have shown a direct relationshipConclusions. Proxies of inflammation and dietary protein
intake exert competing effects on serum albumin and creatinine between CRP concentration and all-cause and cardiovas-
in hemodialysis patients. These data provide a rationale for cular mortality in hemodialysis patients.
prospective testing of dietary protein supplementation in he-
While we now have a better understanding of the re-modialysis patients with biochemical evidence of ongoing in-
lationship between inflammation and proxies of nutri-flammation and “malnutrition.”
tional status, several critical questions remain. What is
the effect of inflammation on serum albumin over time?
How does nutrition modulate the effect of inflammation
on albumin levels? What is the combined effect of in-
Key words: malnutrition, C-reactive protein, nutritional markers, nor-
flammation and nutrition on nonvisceral proteins overmalized protein catabolic rate, protein energy malnutrition, acute phase
response, hypoalbuminemia. time? Is there a meaningful effect of dietary protein
intake on serum albumin or creatinine concentration in
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Table 1. Patient characteristics caused by cardiovascular disease, infection, or other
causes. The dialysis and general medical care providedAge years 58.316.2
Gender % female 47.5 in the units were based on published clinical practice
Race % African American 39.5 guidelines (NKF-DOQI) [15].
Diabetes % 35.0
Vintage years 2.63.4 Statistical analysis(median 1.3, range 0–26.0 years)
Albumin g/dL 3.930.45 Continuous variables were described as mean  SD
Creatinine mg/dL 9.823.32 or median where appropriate and analyzed using theKt/V 1.540.43
Student t test, analysis of variance, or the Wilcoxon ranknPCR g/kg/day 1.000.27
C-reactive protein 19.220.8 sum test where appropriate. The correlation was de-
(median 11.7, range 6.9–255.6) scribed with the Pearson product moment correlation
The average value for each variable for months 6 to 12. coefficient. Categorical variables were described using
proportions and analyzed using the 2 test. CRP was
log transformed to attenuate the influence of very high
values on inference testing. Overall survival was calcu-
individuals by age, sex, or race? To explore these ques- lated using the Kaplan-Meier product limit estimate [16].
tions, we conducted a detailed analysis of longitudinal Proportional hazards (“Cox”) regression was used for
data from a relatively large cohort of hemodialysis pa- all survival analyses (that is, time to death, time to death
tients. While observational, these data provide compel- or hospitalization) [17]. We fit unadjusted, case mix-
ling evidence for the dual control of nutritional status adjusted, and multivariable-adjusted survival models,
by intake and inflammation, and raise additional critical with the latter, including albumin, creatinine, nPCR, he-
questions regarding the optimal management of nutri- matocrit, ferritin, PTH, and Kt/V as candidate variables.
tionally compromised patients with end-stage renal dis- Plots of log [log (survival rate)] against log (survival
ease (ESRD). time) were performed to establish the validity of the
proportionality assumption [18]. All prevalent patients
as of January 1998 (month 1) were used for the survival
METHODS analysis, providing up to 12 months of follow-up. Linear
This study was approved by the institutional review regression was used for the cross-sectional analyses ex-
board of the institution where the patients received treat- amining the relationships among CRP and serum albu-
ment and were studied. Dialyzers used were either F80s min and creatinine. Linear model performance was as-
or F8s (Fresenius Medical Care AG, Bad Homburg, Ger- sessed using total and partial R2 and Mallow’s Cp. The
many). Dialyzers were subject to reuse with citric acid May 1998 cohort (month 5) was arbitrarily chosen for
these analyses. The analysis of repeated measures ofand heat. Baseline and interdialytic body weights were
albumin and creatinine was performed using the Mixednot recorded. No patients received interdialytic paren-
model with an unstructured covariance matrix [19]. Theteral nutrition (IDPN).
Mixed procedure was chosen for its flexibility, as it al-
Patient cohort lowed the incorporation of all available data without
restriction on the number of observations or the presenceAll prevalent hemodialysis patients in two hemodialy-
of missing data. We applied an unstructured variance–sis units at Beth Israel Medical Center (New York, NY,
covariance matrix to obviate assumptions of a particularUSA) as of January 1998 were included in the cohort,
data structure that might otherwise have been requiredas were incident patients who arrived during the calendar
and to ensure that P values were conservatively esti-year. Data on age, sex, race, primary renal disease (dia-
mated. Model fitness was assessed using the Aikaike’s in-betes, hypertension, other), vintage (time since initia-
formation criteria. The July to December cohort (monthstion), and vascular access (fistula, graft, catheter) were re-
7 through 12) was used for these analyses to provide acorded and, with the exception of vascular access, are
sufficiently long follow-up time and efficient use of datapresented in Table 1. The following laboratory studies
points. Only patients with two or more values for serum
were collected during the months of January, May, and albumin or creatinine were included in the analyses.
July through December inclusive: CRP, albumin, creati- For all regression analyses, variables were selected
nine, hematocrit, ferritin, intact parathyroid hormone using backward elimination, with the exit criterion based
(PTH), single-pool Kt/V and normalized protein cata- on P  0.05. For face validity, age, sex, and race were
bolic rate (nPCR). Albumin was measured using the bro- included in all models; the inclusion of other variables
mocresol green method. CRP was measured using a rate depended on the level of statistical significance. The ef-
nephelometer, with a minimum value of 6.9 mg/L. All fect modification was evaluated by the inclusion of multi-
deaths and hospitalizations were recorded. Deaths were plicative interaction terms for selected variables. All
classified as being caused by cardiovascular disease or analyses were conducted using SAS 7.0 (SAS Institute,
Cary, NC, USA).other causes; hospitalizations were classified as being
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To exclude an effect of the initiation of dialysis on seven (24%) were consistently in the lowest tertile. One
hundred forty-eight (62%) were in different tertiles atclinical outcome variables (albumin), we also analyzed
the data following the exclusion of 25 patients who different time points, and 32 (14%) were consistently in
the highest tertile of CRP. Six-month mortality ratesstarted dialysis during the period of observation. Addi-
tionally, any patient who started dialysis within three were 3.5, 6.3, and 9.5% in these groups, corresponding
to annualized rates of 7, 12.6, and 19.0%. Therefore, wemonths of the first of six months was removed and the
data reanalyzed. have no evidence that a “high CRP phenotype” exists
that does not suffer increased risk from the inflammatory
response.
RESULTS
One hundred sixty-six (57%) patients were hospital-
A total of 426 patients were cared for in the two dial- ized at least once over the 12-month study period. There
ysis units over the 12-month study period. The mean age was a significant association between log CRP and all-
was 58.3 16.2 years. Forty-seven percent were women. cause hospitalization (RR 1.25, 95% CI, 1.03 to 1.52),
Thirty-nine percent were African American. Twenty- even after adjusting for diabetes (RR 1.67, 95% CI, 1.22
seven percent were white, and 33% were of other races to 2.29). However, with additional adjustment for serum
or ethnicities. The primary renal diagnosis was roughly albumin, the association between log CRP and hospital-
evenly split among diabetes (35%), hypertension (31%), ization was no longer statistically significant (P  0.48).
and other causes (34%). The mean dialysis vintage was There was no demonstrable association between log
31  41 months (range 1 to 312 months). Among the CRP and cause-specific hospitalization.
initial (month 1) cohort (N  292), the most common
vascular access was an arteriovenous (AV) fistula (43%), Cross-sectional analysis of albumin, creatinine, CRP,
and protein catabolic ratefollowed by an AV graft (34%) and a permanent or
temporary central venous catheter (23%). There was no Kaysen, Stevenson, and Depner have previously shown
significant difference in the types of vascular access when an inverse correlation between log CRP and serum albu-
cataloged during month 5 or months 7 through 12. min and a direct correlation between nPCR and albumin
[7]. The effects of log CRP and nPCR on albumin were
Predictors of mortality and hospitalization in the independent. In the current study, we aimed to validate
initial cohort and extend these findings, simultaneously adjusting for
To confirm findings previously described in smaller additional factors that might influence the serum albu-
cohorts, the association between CRP and mortality and min concentration. The mean serum albumin was 3.88
hospitalization were evaluated in the 292 patient cohort 0.47 g/dL. The estimated multivariable effect of log CRP
alive and on hemodialysis at the start of 1998. The annu- on serum albumin was 0.175 g/dL per unit increase in
alized mortality rate was 12.2%. The median CRP was log CRP (P  0.0001), and the estimated multivariable
9.85 mg/L, and the 10 and 90% limits were 6.9 and effect of nPCR on serum albumin was 0.044 g/dL per
39.9 mg/L, respectively. Stratified by tertiles of CRP, the 0.1 g protein/kg/day increase in nPCR (P  0.0001).
mortality rates were 9.5, 12.7, and 23.7% in tertiles 1, 2, Increased age (P  0.04) and diabetes (P  0.02) were
and 3, respectively (P  0.01). In the unadjusted Cox associated with lower serum albumin, and male sex (P
model, the relative risk (RR) and 95% CI associated 0.0008) was associated with higher serum albumin con-
with a unit increase in log CRP was 1.96 (95% CI, 1.40 centrations. Log CRP explained the largest fraction of
to 2.75). Adjusting for case mix, the RR was 1.76 (95% the variance in albumin (partial R 2  0.13), and nPCR
CI, 1.26 to 2.46). After an additional adjustment for explained the next largest fraction (partial R 2  0.07).
serum albumin and dialysis dose, the RR associated with While the complex interplay among six variables cannot
a unit increase in log CRP was 1.55 (95% CI, 1.08 to be graphically displayed, Figure 1 shows the log CRP,
2.25), despite colinearity between log CRP and albumin nPCR, and serum albumin in three dimensions, high-
(Pearson r  0.30, P  0.0001). As expected, the RR lighting the “dual influence” of inflammation and dietary
of death increased with age and diabetes and decreased intake on serum albumin. Note the scarcity of data points
with increasing serum albumin (RR 0.42, 95% CI, 0.23 in the right hand panel of Figure 1 corresponding to
to 0.79 per g/dL increase). A negative coefficient for patients spontaneously having an nPCR 1.2 and a log
the linear Kt/V term and a positive coefficient for the CRP in the upper tertile.
quadratic Kt/V term confirmed the J-shaped relationship Strikingly similar results were observed for the serum
between Kt/V and mortality [20]. There was no associa- creatinine concentration. The mean serum creatinine
tion between nPCR and mortality. was 9.69  3.11 mg/dL. The estimated multivariable ef-
To explore the effect of CRP variability on survival, fect of log CRP on serum creatinine was 0.472 mg/dL
the study sample was restricted to those patients who per unit increase in log CRP (P  0.002), indicating
an association between inflammation and muscle mass,had CRP values in months 1, 5, and 7 (N  237). Fifty-
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Fig. 1. Relationship between the dependent variable, serum albumin and normalized protein catabolic rate (nPCR), a representative of protein
catabolism, and log transformed C-reactive protein (CRP) is represented as a plane. These variables are statistically independent. The individual
data points are represented as open symbols. As CRP increases, albumin decreases, but this effect is modulated by nPCR. If the data array are
rotated around the axis describing serum albumin concentration (right panel), it is evident that very few patients have a value for nPCR greater
than 1.2 g/kg/day when log CRP is greater than 1.5. Data are presented from month 5, randomly selected. Creatinine  9.597  (1.761 * log
CRP)  (2.070 * nPCR). N  288; R  0.307; log CRP  0.001; nPCR  0.001.
since the association was present after adjusting for the concentration. We tested for effect modification of in-
flammation and dietary protein intake on albumin andeffects of Kt/V on serum creatinine. The multivariable
effect of nPCR on serum creatinine was 0.304 mg/dL creatinine by creating multiplicative interaction terms of
log CRP (for example, log CRP 	 age, log CRP 	 sex)per 0.1 g protein/kg/day increase in nPCR (P  0.0001).
Increased age (P  0.0001), diabetes (P  0.0001), and and nPCR (for example, nPCR 	 age, nPCR 	 sex).
There were 364 patients with at least two serum albu-Kt/V (P 0.0001) were associated with lower creatinine,
and male sex (P  0.0001) and African American race min determinations during the six-month period of study.
The overall trend in serum albumin concentration was(P  0.0001) were associated with higher serum creati-
nine concentrations. Overall, 52% of the variance in estimated at 0.039 g/dL/month. Log CRP was the most
important determinant of serum albumin concentrationserum creatinine could be explained by these factors. It
is noteworthy that the nPCR explained more variation over time. Averaged across all patients, the effect of log
CRP on serum albumin was 0.124 g/dL/month (P in serum creatinine than either race or gender. Figure 2
shows the relationships among log CRP, nPCR, and se- 0.0001, per unit increase in log CRP). nPCR was also
a key determinant of serum albumin (influencing therum creatinine.
albumin trend more so than age, sex, race, or diabetes).
Longitudinal analysis using Mixed models Per 0.1 g protein/kg/day increase in nPCR, the serum
albumin increased 0.021 g/dL/month (P  0.0001). Re-Longitudinal models were conducted using repeated
measures of serum albumin and creatinine as dependent moval of the 25 incident patients yielded no significant
difference in the albumin over time-parameter estimatevariables, and we focused on the influence of a marker
of inflammation (log CRP) and dietary protein intake (0.039 g/dL/month, P  0.0001). Also, when patients
who had started dialysis within three months of the initia-(nPCR) on the time trends in albumin and creatinine.
All models were adjusted for age, sex, race, and diabetes. tion of this study were removed, there was still a signifi-
cant difference in the trend of albumin over timeIn the case of creatinine, models were also adjusted for
Kt/V given the effects of dialysis on serum creatinine (0.037 g/dL/month, P  0.0001, N  271, rather than
Kaysen et al: Dietary protein in HD patients 337
Fig. 2. Relationship between the dependent variable, creatinine and nPCR, and log-transformed CRP concentration is represented on a plane.
The individual data points are represented as open symbols. Albumin  3.877  (0.409 * log CRP)  (0.481 * nPCR). N  287; R  0.449; log
CRP  0.001; nPCR  0.001.
364). Thus, the increase in serum albumin over time was sex, race, and diabetes, vintage and Kt/V were signifi-
cantly associated with the serum creatinine trend.not due solely to changes among incident patients or
The longitudinal analysis of serum creatinine con-patients starting dialysis 90 or fewer days earlier.
firmed the cross-sectional results, indicating a significantThere was a significant interaction between log CRP
effect of inflammation on serum creatinine over time.and race (P 0.02), with African-American race attenu-
Per unit increase in log CRP, there was a0.142 mg/dL/ating the (negative) effect of inflammation on serum albu-
month decrease in serum creatinine concentration.min concentration. The effect of log CRP on serum albu-
There were no significant interactions among nPCR ormin was 0.108 g/dL/month among African Americans,
log CRP and other covariates on the trends in serumcompared with 0.141 g/dL/month among the non-Afri-
creatinine.can Americans, corresponding to a 23% relative decrease
Two additional longitudinal analyses were conducted.in the effect. There was a highly significant interaction
The first was to confirm the validity of the Mixed modelbetween log CRP and nPCR (P  0.0001). Considering
by examining the effect of log CRP on hematocrit, asthe trend in serum albumin over time, the overall effect
inflammation is well known to promote erythropoietinof inflammation (log CRP) was negative, and the overall
resistance, and to decrease erythrocyte production. In-effect of dietary protein intake (nPCR) was positive. How-
deed, there was a significant effect of log CRP on hema-ever, lower dietary protein intake tended to facilitate
tocrit (1.0% hematocrit per month per unit increasethe adverse effects of inflammation, while higher dietary
in log CRP, P  0.0001), with or without adjusting forprotein intake tended to defend against those effects.
case mix and other laboratory variables. We then ex-Finally, there was a minuscule effect of Kt/V on serum
plored whether there was an effect of inflammation onalbumin (0.005 g/dL/month per 0.1 increase in Kt/V)
dietary intake, using nPCR as the dependent variable inthat did not reach statistical significance (P  0.053).
another Mixed analysis. This model showed a small effectThere were 352 patients with at least two serum creati-
of log CRP on serial nPCR (0.032 g/kg/day per unit
nine determinations during the six-month period of study. increase in log CRP, P  0.0002).
The overall trend in serum creatinine concentration over
time was estimated at 0.052 mg/dL/month. nPCR was
DISCUSSIONthe most important determinant of serum creatinine con-
centration, with an effect of 0.183 mg/dL/month per 0.1 g Hypoalbuminemia is a potent risk factor for mortality
and morbidity in ESRD and in other populations, includ-protein/kg/day increase (P 0.0001). In addition to age,
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ing the older patients and individuals undergoing a vari- compared with albumin [33]. Nevertheless, in cross-sec-
tional studies, the concentrations of markers of inflam-ety of types of noncardiac surgery [21, 22]. While reduced
dietary intake can lead to hypoalbuminemia, these ef- mation vary in lock step with the concentration of albu-
min [31]. The cross-sectional and longitudinal results arefects are generally mild. In a prospective 24-week study
in which healthy volunteers were subjected to semistar- consistent with what has been reported about the effects
of inflammation both on albumin concentration and syn-vation (1500 kcal/24 h), serum albumin decreased only
moderately (from 4.28 to 3.86 g/dL) in spite of a 23% thetic rate [34] as well as on muscle protein [35, 36]. The
observation that higher protein intake may attenuate thereduction in body weight and muscle mass [23]. There-
fore, more significant reductions in serum albumin con- effects of inflammation is consistent with results from
prospectively controlled trials in which nutrient intakecentration reflect processes beyond nutrient deprivation,
specifically external losses (as with peritoneal dialysis) was intentionally controlled in patients following trauma
[37, 38] and during recovery from trauma [39].and inflammation [24].
Serum albumin levels decrease with inflammation be- The individuals described herein were not asked to
modify their diet for the purpose of this investigation.cause of several factors, including reduced synthesis,
increased catabolism, and translocation of albumin to Interestingly, very few patients with high CRP values
have nPCR in excess of 1.0 g protein/kg/day (Figs. 1extravascular pools [25]. It is unlikely that hypoalbu-
minemia per se directly causes events that precipitate and 2, right panels). If one were to extrapolate the Mixed
models, increases in nPCR above 1.0 g protein/kg/daymortality. Despite the important functions served by al-
bumin, hereditary analbuminemia is compatible with might either slightly increase or attenuate the decrease
in serum albumin and creatinine concentrations duringnormal life. Individuals with hereditary analbuminemia
are essentially asymptomatic and present primarily with episodes of inflammation.
Figures 1 and 2 are each three-dimensional plots repre-hyperlipidemia [26]. This observation suggests that the
underlying processes associated with hypoalbuminemia senting a single cross section in time of the patient popu-
lation. Even within this randomly selected cross-section,are responsible for the increased risk of death in ESRD,
rather than the low level of albumin itself. it is clear that at nPCR 1.2, the relationship between
log CRP and both albumin and creatinine is relativelyWhile the link between hypoalbuminemia and mortal-
ity may be largely explained by albumin (or cholesterol flat, in contrast to what is seen for nPCR1.0. Thus, even
within the range observed here, there is attenuation ofor prealbumin) behaving as a negative acute phase re-
actant, this mechanism does not fully explain why pre- the effect of increased CRP. While it is not possible to
present graphically the interaction between these vari-dialysis serum urea nitrogen, serum creatinine, and
nPCR have also been inversely correlated with mortality ables over time, if one dichotomizes to nPCR 1.0 vs.
nPCR 1.0, we see a difference (0.1157 vs. 0.1368in several studies. TNF- and IL-1 directly suppress ap-
petite [27, 28]. Cytokines may also induce catabolism, g/dL/month per log unit increase in CRP). Of note, there
are very few patients who spontaneously have an nPCRleading to a wasting illness that is indistinguishable from
prolonged starvation. In particular, IL-6 and TNF- in- 1.0 and high levels of CRP simultaneously. Our data
suggest that this group, while small, suffer less of an effectduce muscle breakdown in rats, and IL-6 appears to
mediate experimental cancer cachexia [29]. Administer- of increased CRP on the outcome variables measured
(albumin and creatinine). We think this is an importanting IL-6 receptor antibodies prevented these effects in
mice transgenic for IL-6 [30]. Therefore, the inflamma- observation because it might be possible to modulate
the effects of inflammation intentionally by increasingtory response may induce protein-energy malnutrition
by decreased intake, in addition to increased catabolism. protein and calorie intake, and thus increasing nPCR by
intent. Alternatively, the patients who continue to haveOf note, should infection cause negative nitrogen bal-
ance in the context of these studies, then nPCR should a high nPCR during inflammation may have other sig-
nificant differences than those who do not, and theyoverestimate the effect of dietary protein. Thus, our sta-
tistical analysis of the effect of nPCR on outcome vari- may just reflect different populations. For example, since
cytokines directly suppress appetite, those patients whoables (creatinine and albumin) is weighted against us.
Indeed, had we a direct measure of nitrogen intake, the continue to spontaneously eat adequately despite ele-
vated CRP levels may have less systemic inflammation.associations may have been stronger.
We have recently established that inflammation in the We have previously reported an association between
the administration of IDPN and survival in maintenancehemodialysis patient population is also a dynamic pro-
cess [31]. The levels of acute phase proteins vary widely, hemodialysis patients [40]. More than 1600 patients who
had received IDPN were compared with 
22,000 non-while serum albumin concentration varies on a far
smaller scale. The reason for this is the much larger range IDPN recipient controls, adjusting for age, sex, race,
diabetes, serum creatinine, and dialysis dose. Amongin available values for the major acute phase proteins,
such as CRP, and the much shorter half-lives [32] when individuals with hypoalbuminemia, there was a signifi-
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cant reduction in the odds of death at one year. Among rectly increase serum albumin and creatinine, other fac-
tors confounding both nPCR and albumin may be opera-individuals whose initial serum albumin concentration
was3.0 g/dL, the odds of death were 0.70, or 30% below tive. We believe that inflammation is one of these factors;
if this is indeed true, we depend on CRP alone to fullyexpected. The increase in survival was accompanied by
steady increases in the mean serum albumin and creati- adjust for the effects of inflammation. CRP levels change
rapidly, and our measurements were made monthly,nine concentrations during the months after starting
IDPN. Our present findings suggest that intentionally leaving potential gaps in our periods of observation.
More long-lived acute phase proteins, such as 1 acidincreasing protein and calorie intake within the popula-
tion of dialysis patients who have increased CRP levels glycoprotein, fibrinogen, or ceruloplasmin, may provide
additional information if available. We may also be ablemight improve serum albumin and survival. IDPN in-
deed may provide such a means. To establish a positive to develop a more comprehensive understanding of the
inflammation-intake paradigm by consideration of cyto-effect would require prospective trials.
This study has several important limitations. First, the kines (for example, IL-1, IL-6, TNF-) or negative acute
CRP assay was insensitive in the lower range. The chosen phase proteins (for example, prealbumin and transferrin)
assay resulted in some misclassification, in that the refer- in future studies.
ent CRP group included patients with very low and low In summary, inflammation and dietary protein intake
CRP values who could not be differentiated. This would exert competing effects on serum albumin and creatinine
have diminished the RR estimates of higher CRP con- over time that are statistically significant and clinically
centrations. Using a more sensitive assay, we found a meaningful. Therapeutically, the model would predict
significantly increased risk when patients with CRP val- that by increasing nPCR from 0.8 to 1.2 g/kg/day, one
ues between 2.6 and 5.2 g/mL and patients with CRP might expect an increase in albumin of approximately
values 2.6 g/mL were compared [12]. More impor- 0.5 g/dL and an increase in creatinine of approximately
tantly, the “floor” induced by the assay may have resulted 4.4 mg/dL over a six-month period, all else being equal.
in slightly inaccurate effect estimates (on serum albumin The effects of increased dietary protein intake on albu-
and creatinine). However, the effects of CRP on albumin min might be accentuated in the face of inflammation.
and creatinine are a function of the log of CRP and are While the aphorism of old may be “feed a cold, starve
thus amplified at very high levels, and quite small and a fever” [41], at least among hemodialysis patients with
indeed undetectable statistically when the levels are low. biochemical evidence of inflammation, the opposite ther-
The insensitivity of the assay used for CRP is therefore apeutic strategy of protein–nutritional supplementation
unlikely to have affected the observed interactions sig- should be prospectively tested in clinical trials.
nificantly. While important to consider, this limitation
would not have affected the qualitative results. Second, ACKNOWLEDGMENT
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